Instrument Inactif

Autres langues Raptor Pharmaceutical Corp

Actions

US75382F1066

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2016	Depomed : Le laboratoire Depomed résigné à se vendre-sources	RE
2015	Apple : Les valeurs à suivre sur les marchés aùéricains	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Exclusive: Drugmaker Depomed prepares to explore a sale - sources	15/09/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Shareholders To Contact The Firm For Additional Information	15/09/16
Raptor Pharmaceutical : Acquisition May Not Be in the Best Interests of RPTP Shareholders	14/09/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Investors To Contact The Firm For Additional Information	12/09/16
RAPTOR PHARMACEUTICAL CORP. Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Horizon Pharma plc	12/09/16
Raptor Pharmaceutical Presents Results from Meta-Analysis Demonstrating Efficacy of QUINSAIR™ Comparable to Other Approved, Inhaled Antibiotics in Cystic Fibrosis Patients	07/09/16
Raptor Pharmaceutical to Present Data on QUINSAIR™ and Other Inhaled Antibiotics at the ERS International Congress	24/08/16
Raptor Pharmaceutical : Voted A "Best Places to Work" Company in the North San Francisco Bay Area	18/08/16
Raptor Pharmaceutical Voted A “Best Places to Work” Company in the North San Francisco Bay Area	18/08/16
Raptor Pharmaceutical : Biotech Stocks Technical Report -- Incyte, BioDelivery Sciences Intl., Synthetic Biologics, and Raptor Pharma	16/08/16
Raptor Pharmaceutical Corp. Reports Second Quarter 2016 Financial Results	04/08/16
Raptor Pharmaceutical to Hold Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4, 2016, at 4:30 p.m. EDT	28/07/16
Raptor Pharmaceutical to Participate in the 2016 JMP Life Sciences Conference	14/06/16
Raptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR™ at the 39th European Cystic Fibrosis Conference	10/06/16
Raptor Pharmaceutical : to Present Data on QUINSAIR™ at European Cystic Fibrosis Conference	07/06/16
Raptor Pharmaceutical to Present Data on QUINSAIR™ at European Cystic Fibrosis Conference	07/06/16
Raptor Pharmaceutical Corp. Reports First Quarter 2016 Financial Results	05/05/16
Raptor Pharmaceutical to Hold First Quarter 2016 Financial Results Conference Call and Webcast on Thursday, May 5, 2016, at 4:30 p.m. ET	28/04/16
Raptor Pharmaceutical Launches QUINSAIR™ in Europe	11/04/16
Raptor Pharmaceutical : PROCYSBI® New Drug Submission Accepted by Health Canada with Priority Review	21/03/16

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Raptor Pharmaceutical Corp

Actions

US75382F1066

Autres langues

Filtres